Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-20 of 20

Sort by

Sort Order Select

Journal Articles

Abstract B63: Survivorship, vision, and eye salvage following pars plana vitrectomy for residual active or recurrent retinoblastoma

Junyang Zhao, Zhao Xun Feng, Qiyan Li, Songyi Wu, Liwen Jin, Brenda L. Gallie

Cancer Res (2020) 80 (14_Supplement): B63.

https://doi.org/10.1158/1538-7445.PEDCA19-B63

Published: 15 July 2020

View articletitled, Abstract B63: Survivorship, vision, and eye salvage following pars plana vitrectomy for residual active or recurrent retinoblastoma

Journal Articles

Abstract 3771: Oncogenes and tumour-suppressors drive differential retinoblastoma evolution

Adriana Salcedo, John D. Watson, Hilary Racher, Diane Rushlow, Shadrielle Melijah G. Espiritu, Doroto H. Sendorek, Stephenie D. Prokopec, Donco Matveski, Fouad Yousif, Julie Livingstone, Brenda L. Gallie, Paul C. Boutros

Cancer Res (2019) 79 (13_Supplement): 3771.

https://doi.org/10.1158/1538-7445.AM2019-3771

Published: 01 July 2019

View articletitled, Abstract 3771: Oncogenes and tumour-suppressors drive differential retinoblastoma evolution

Journal Articles

Abstract 767: Cyclosporin-modulated intensified-dosage chemotherapy for saving eyes with Group D intraocular retinoblastoma

Helen S.L. Chan, Elise Héon, A Linn Murphree, Paulita P. Astudillo, Helen Dimaras, Furqan Shaikh, Brenda L. Gallie

Cancer Res (2014) 74 (19_Supplement): 767.

https://doi.org/10.1158/1538-7445.AM2014-767

Published: 01 October 2014

View articletitled, Abstract 767: Cyclosporin-modulated intensified-dosage chemotherapy for saving eyes with Group D intraocular retinoblastoma

Journal Articles

Abstract 1333: Specific RB1 mutations and risk of subsequent neoplasms among survivors of hereditary retinoblastoma.

Lindsay M. Morton, Jeannette R. Wong, Brenda L. Gallie, David H. Abramson, Johanna M. Seddon, Michael Dean, Bert Gold, Alisa M. Goldstein, Ruth A. Kleinerman, Margaret A. Tucker

Cancer Res (2013) 73 (8_Supplement): 1333.

https://doi.org/10.1158/1538-7445.AM2013-1333

Published: 15 April 2013

View articletitled, Abstract 1333: Specific RB1 mutations and risk of subsequent neoplasms among survivors of hereditary retinoblastoma.

Journal Articles

Abstract 958: Improving survival of extraocular, metastatic and trilateral retinoblastoma patients with combined intensive therapy.

Helen SL Chan, Elise Héon, Tal Schechter, Helen Dimaras, Brenda L. Gallie, John J. Doyle

Cancer Res (2013) 73 (8_Supplement): 958.

https://doi.org/10.1158/1538-7445.AM2013-958

Published: 15 April 2013

View articletitled, Abstract 958: Improving survival of extraocular, metastatic and trilateral retinoblastoma patients with combined intensive therapy.

Journal Articles

Abstract 809: Prenatal and postnatal management of infants at 100%-risk for developing retinoblastoma

Helen S.L. Chan, Helen Dimaras, Elise Héon, Vikas Khetan, Brenda L. Gallie

Cancer Res (2012) 72 (8_Supplement): 809.

https://doi.org/10.1158/1538-7445.AM2012-809

Published: 15 April 2012

View articletitled, Abstract 809: Prenatal and postnatal management of infants at 100%-risk for developing retinoblastoma

Journal Articles

Abstract 694: Cyclosporin-modulated intensified dosage chemotherapy well-tolerated for saving eyes with intraocular retinoblastoma

Helen S.L Chan, Elise Héon, Helen Dimaras, Brenda L. Gallie

Cancer Res (2011) 71 (8_Supplement): 694.

https://doi.org/10.1158/1538-7445.AM2011-694

Published: 15 April 2011

View articletitled, Abstract 694: Cyclosporin-modulated intensified dosage chemotherapy well-tolerated for saving eyes with intraocular retinoblastoma

Journal Articles

Abstract 4361: Retinoblastoma (RB) genomic progression analysis using Tissue Microarrays (TMA) comprising 121 RB patient tumors

Crystal N. D'Silva, Maisa Yoshimoto, Renato Natalino, Fernando Soares, Celia Antoneli, Karina Ribeiro, William Halliday, Brenda L. Gallie, Jeremy A. Squire

Cancer Res (2010) 70 (8_Supplement): 4361.

https://doi.org/10.1158/1538-7445.AM10-4361

Published: 15 April 2010

View articletitled, Abstract 4361: Retinoblastoma (RB) genomic progression analysis using Tissue Microarrays (TMA) comprising 121 RB patient tumors

Journal Articles

Abstract 3535: Retinoblastoma cerebrospinal fluid metastases treatable by intensive intraventricular and multidrug resistance-reversal systemic chemotherapy without radiation

Helen S. L. Chan, Elise Héon, John J. Doyle, Helen Dimaras, Brenda L. Gallie

Cancer Res (2010) 70 (8_Supplement): 3535.

https://doi.org/10.1158/1538-7445.AM10-3535

Published: 15 April 2010

View articletitled, Abstract 3535: Retinoblastoma cerebrospinal fluid metastases treatable by intensive intraventricular and multidrug resistance-reversal systemic chemotherapy without radiation

Journal Articles

Molecular RB1 gene detection of minimal residual disease in metastatic retinoblastoma

Helen S. L. Chan, Diane Rushlow, John Doyle, James Williams, Esteban M. Abella, Elise Héon, Brenda L. Gallie

Cancer Res (2006) 66 (8_Supplement): 1021.

Published: 15 April 2006

View articletitled, Molecular RB1 gene detection of minimal residual disease in metastatic retinoblastoma

Journal Articles

KIF14 is a candidate oncogene in the 1q minimal region of genomic gain in multiple cancers

Timothy W. Corson, Clarellen Spencer, Annie Huang, Ming-Sound Tsao, Brenda L. Gallie

Cancer Res (2005) 65 (9_Supplement): 1434.

Published: 01 May 2005

View articletitled, KIF14 is a candidate oncogene in the 1q minimal region of genomic gain in multiple cancers

Journal Articles

Good long term results of multidrug resistance-reversal chemotherapy for advanced intraocular retinoblastoma without upfront elective consolidation radiation

Helen S. L. Chan, Elise Heon, Nesan Bandali, Andrew S. Budning, Brenda L. Gallie

Cancer Res (2005) 65 (9_Supplement): 1117.

Published: 01 May 2005

View articletitled, Good long term results of multidrug resistance-reversal chemotherapy for advanced intraocular retinoblastoma without upfront elective consolidation radiation

Journal Articles

Saving eyes with International Classification Groups C and D intraocular retinoblastoma without radiation by high-dose chemotherapy with cyclosporine and focal cryo/laser therapy.

Helen S. Chan, Elise Heon, Andrew Budning, Brenda L. Gallie

Cancer Res (2004) 64 (7_Supplement): 720.

Published: 01 April 2004

View articletitled, Saving eyes with International Classification Groups C and D intraocular retinoblastoma without radiation by high-dose chemotherapy with cyclosporine and focal cryo/laser therapy.

Journal Articles

Cyclosporine-modulated chemotherapy with focal cryo/laser therapy may successfully cure some relapsed heavily pretreated intraocular retinoblastoma.

Helen S. Chan, Elise Heon, Andrew Budning, Brenda L. Gallie

Cancer Res (2004) 64 (7_Supplement): 720.

Published: 01 April 2004

View articletitled, Cyclosporine-modulated chemotherapy with focal cryo/laser therapy may successfully cure some relapsed heavily pretreated intraocular retinoblastoma.

Journal Articles

Genomic Amplification in Retinoblastoma Narrowed to 0.6 Megabase on Chromosome 6p Containing a Kinesin-like Gene, RBKIN

Danian Chen, Sanja Pajovic, Allison Duckett, Vivette D. Brown, Jeremy A. Squire, Brenda L. Gallie

Cancer Res (2002) 62 (4): 967–971.

Published: 01 February 2002

View articletitled, Genomic Amplification in Retinoblastoma Narrowed to 0.6 Megabase on Chromosome 6p Containing a Kinesin-like Gene, RBKIN

Journal Articles

Developmental Basis of Retinal-specific Induction of Cancer by RB Mutation

Brenda L. Gallie, Christine Campbell, Hollie Devlin, Allison Duckett, Jeremy A. Squire

Cancer Res (1999) 59 (7_Supplement): 1731s–1735s.

Published: 01 April 1999

View articletitled, Developmental Basis of Retinal-specific Induction of Cancer by RB Mutation

Journal Articles

Multidrug Resistance Protein (MRP) Expression in Retinoblastoma Correlates with the Rare Failure of Chemotherapy despite Cyclosporine for Reversal of P-Glycoprotein

Helen S. L. Chan, Ying Lu, Thomas M. Grogan, George Haddad, David R. Hipfner, Susan P. C. Cole, Roger G. Deeley, Victor Ling, Brenda L. Gallie

Cancer Res (1997) 57 (12): 2325–2330.

Published: 01 June 1997

View articletitled, Multidrug Resistance Protein (MRP) Expression in Retinoblastoma Correlates with the Rare Failure of Chemotherapy despite Cyclosporine for Reversal of P-Glycoprotein

Journal Articles

Mutations of the p53 Gene Do Not Occur in Testis Cancer

Hong-Qi Peng, David Hogg, David Malkin, Denis Bailey, Brenda L. Gallie, Mohammed Bulbul, Michael Jewett, Janet Buchanan, Paul E. Goss

Cancer Res (1993) 53 (15): 3574–3578.

Published: 01 August 1993

View articletitled, Mutations of the p53 Gene Do Not Occur in Testis Cancer

Journal Articles

Failure of RB1 to Reverse the Malignant Phenotype of Human Tumor Cell Lines

Michelle M. Muncaster, Brenda L. Cohen, Robert A. Phillips, Brenda L. Gallie

Cancer Res (1992) 52 (3): 654–661.

Published: 01 February 1992

View articletitled, Failure of RB1 to Reverse the Malignant Phenotype of Human Tumor Cell Lines

Journal Articles

Reproducible Growth in Tissue Culture of Retinoblastoma Tumor Specimens

Brenda L. Gallie, Wendy Holmes, Robert A. Phillips

Cancer Res (1982) 42 (1): 301–305.

Published: 01 January 1982

View articletitled, Reproducible Growth in Tissue Culture of Retinoblastoma Tumor Specimens

Update search

NARROW

Format

Journal

Article Type

Issue Section

Date

Availability

Abstract B63: Survivorship, vision, and eye salvage following pars plana vitrectomy for residual active or recurrent retinoblastoma

Abstract 3771: Oncogenes and tumour-suppressors drive differential retinoblastoma evolution

Abstract 767: Cyclosporin-modulated intensified-dosage chemotherapy for saving eyes with Group D intraocular retinoblastoma

Abstract 1333: Specific RB1 mutations and risk of subsequent neoplasms among survivors of hereditary retinoblastoma.

Abstract 958: Improving survival of extraocular, metastatic and trilateral retinoblastoma patients with combined intensive therapy.

Abstract 809: Prenatal and postnatal management of infants at 100%-risk for developing retinoblastoma

Abstract 694: Cyclosporin-modulated intensified dosage chemotherapy well-tolerated for saving eyes with intraocular retinoblastoma

Abstract 4361: Retinoblastoma (RB) genomic progression analysis using Tissue Microarrays (TMA) comprising 121 RB patient tumors

Abstract 3535: Retinoblastoma cerebrospinal fluid metastases treatable by intensive intraventricular and multidrug resistance-reversal systemic chemotherapy without radiation

Molecular RB1 gene detection of minimal residual disease in metastatic retinoblastoma

KIF14 is a candidate oncogene in the 1q minimal region of genomic gain in multiple cancers

Good long term results of multidrug resistance-reversal chemotherapy for advanced intraocular retinoblastoma without upfront elective consolidation radiation

Saving eyes with International Classification Groups C and D intraocular retinoblastoma without radiation by high-dose chemotherapy with cyclosporine and focal cryo/laser therapy.

Cyclosporine-modulated chemotherapy with focal cryo/laser therapy may successfully cure some relapsed heavily pretreated intraocular retinoblastoma.

Genomic Amplification in Retinoblastoma Narrowed to 0.6 Megabase on Chromosome 6p Containing a Kinesin-like Gene, RBKIN

Developmental Basis of Retinal-specific Induction of Cancer by RB Mutation

Multidrug Resistance Protein (MRP) Expression in Retinoblastoma Correlates with the Rare Failure of Chemotherapy despite Cyclosporine for Reversal of P-Glycoprotein

Mutations of the p53 Gene Do Not Occur in Testis Cancer

Failure of RB1 to Reverse the Malignant Phenotype of Human Tumor Cell Lines

Reproducible Growth in Tissue Culture of Retinoblastoma Tumor Specimens

Email alerts

AACR Journals

Update search

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only